Casa Sollievo Della Sofferenza

Neurological Disorders

Clinical research at Casa Sollievo Della Sofferenza is centered on amyotrophic lateral sclerosis, with attention to motor neuron degeneration, progressive neuromuscular impairment, and disease-related functional decline.

  • Amyotrophic lateral sclerosis
  • Motor neuron disease
  • Neuromuscular dysfunction

The hospital’s research activity in this area is linked to clinical investigation of advanced approaches for severe neurodegenerative conditions.

Cell-Based Neurologic Therapy

The sponsor’s funded research includes neural stem cell intervention for central nervous system disorders, reflecting interest in regenerative strategies for neurological disease.

  • Neural stem cells
  • Intracerebroventricular administration
  • Regenerative neurology

This therapeutic focus places emphasis on biologic treatment concepts for disorders affecting neuronal survival and function.

Safety and Tolerability in Neurologic Treatment

Clinical interest also extends to safety evaluation in patients receiving advanced biologic therapy, with attention to adverse events and treatment-related tolerability in a neurological setting.

  • Safety monitoring
  • Adverse event assessment
  • Treatment tolerability

This area supports careful clinical oversight of novel interventions for amyotrophic lateral sclerosis.

Multicenter Clinical Collaboration

The sponsor’s research activity involves collaboration across multiple sites in Italy, supporting coordinated clinical work in specialist neurology and rare disease care.

  • Multicenter collaboration
  • Rare disease research
  • Specialist hospital-based care

Its clinical setting in San Giovanni Rotondo is associated with research in complex neurodegenerative disease management.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on Neural Stem Cell and Sodium Chloride Treatment for Patients with Amyotrophic Lateral Sclerosis

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Italy